Notice of Cipher Pharmaceuticals Inc. Q3 2014 Conference Call

About this update from Cipher Pharmaceuticals Inc.

[{"type":"text","content":"\n\n\nToronto Stock Exchange Symbol: DND\n\n\nMISSISSAUGA, ON, Oct. 20, 2014 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:\n DND) (OTC: CPHMF), today announced it will host a conference call for\n its Q3 2014 financial results on Wednesday, October 29, 2014.\n\n\nQ3 2014 CONFERENCE CALL\n\n\nWHEN: Wednesday, October 29, 2014 at 8:30AM ET\n\n\nCONFERENCE CALL/WEBCAST: You can join the call by dialing 647-427-7450\n or 1-888-231-8191. A live audio webcast will be available through http://www.cipherpharma.com or http://bit.ly/1nx9i5o an archived replay of the webcast will be available for 365 days.\n\n\nAbout Cipher Pharmaceuticals Inc.\n\n\nCipher Pharmaceuticals (TSX: DND) is a growing specialty pharmaceutical\n company with three commercial products and a fourth in development,\n which are improved formulations of successful marketed drugs. We\n acquire products that fulfill high unmet medical needs, manage the\n required clinical development and regulatory approval process, and\n market those products either directly or through partners.\n\n\nOur core capabilities include clinical and regulatory affairs, product\n licensing, supply chain management, and marketing and sales. Since the\n Company was founded in 2000, we have achieved regulatory marketing\n approval in the U.S. and Canada for all three of our original products\n and completed eight marketing partnerships, generating growing revenue\n streams and shareholder value.\n\n\nFor more information, please visit www.cipherpharma.com.\n\n\nSOURCE Cipher Pharmaceuticals Inc.\n\n\n\n Craig Armitage Investor Relations TMX Equicom (416) 815-0700 ext 278 (416) 815-0080 fax [email protected] Shawn Patrick O'Brien Chief Executive Officer Cipher Pharmaceuticals (905) 602-5840 ext 325 (905) 602-0628 fax [email protected] Copyright CNW Group 2014","length":2766,"tagName":"div"}]

More updates from Cipher Pharmaceuticals Inc.